L3VLUP
ProSign in

XRAY · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

XRAYJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • XRAY
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterXRAYJNJ
Q3 202014 holders, $2.3bn30 holders, $26.2bn
Q4 202011 holders, $2.7bn32 holders, $26.6bn
Q1 202116 holders, $3.7bn31 holders, $25.3bn
Q2 202123 holders, $3.8bn37 holders, $25.6bn
Q3 202118 holders, $3.3bn40 holders, $24.1bn
Q4 202113 holders, $2.8bn33 holders, $25.2bn
Q1 202216 holders, $2.8bn35 holders, $28.2bn
Q2 202218 holders, $2.0bn33 holders, $26.9bn
Q3 202217 holders, $1.5bn36 holders, $25.4bn
Q4 202214 holders, $1.6bn35 holders, $27.6bn
Q1 202311 holders, $2.2bn42 holders, $24.5bn
Q2 202310 holders, $1.9bn38 holders, $25.0bn
Q3 202315 holders, $1.7bn37 holders, $18.9bn
Q4 202313 holders, $1.7bn31 holders, $19.0bn
Q1 202412 holders, $1.1bn32 holders, $19.7bn
Q2 20249 holders, $781m35 holders, $20.4bn
Q3 20248 holders, $941m28 holders, $22.3bn
Q4 20249 holders, $648m37 holders, $20.4bn
Q1 20259 holders, $586m32 holders, $20.5bn
Q2 20258 holders, $639m31 holders, $18.4bn
Q3 20256 holders, $369m32 holders, $23.7bn
Q4 20255 holders, $199m29 holders, $27.8bn
Q1 20267 holders, $273m34 holders, $35.6bn
Q2 20265 holders, $61m33 holders, $39.1bn
XRAY

Dentsply Sirona Inc

Holders
13
Reported value
$1.7bn
Buyers
9
Sellers
7

Breadth +2 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 37 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only XRAY (6)

ARK Investment Management LLC, Arrowstreet Capital LP, Artisan Partners LP, First Eagle Investment Management LLC, Marshall Wace LLP, Winton Group Ltd

Only JNJ (24)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, Susquehanna International Group LLP, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →